Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines

Urology

Volumn 53, Issue 6, 1999, Pages 1252-1257

  Morcos, Edward ^b   Jansson, Olof T ^b   Adolfsson, Jan ^b   Kratz, Gunnar ^b   Peter Wiklund, N ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BCG VACCINE; CALCIUM; CYTOKINE; DNA; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER GROWTH; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UROTHELIUM;

ARGININE; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0033152736     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00033-3     Document Type: Article

References (22)

1. Knowles RG, and Moncada S: Nitric oxide synthases in mammals. Biochem J 298: 249-258, 1994.
2. Moncada S, and Higgs A: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9: 1319-1330, 1995.
3. Radomski MW, Jenkins DC, Holmes L, et al: Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines the ability to aggregate platelets. Cancer Res 51: 6073-6078, 1991.
4. Jenkins DC, Charles IG, Baylis SA, et al: Human colon cancer cell lines show a diverse pattern of nitric oxide synthase expression and nitric oxide generation. Br J Cancer 70: 847-849, 1994.
5. Thomsen LL, Lawton FG, Knowles RG, et al: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354, 1994.
6. Jenkins DC, Charles IG, Thomsen LL, et al: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92: 4392-4396, 1995.
7. Edwards P, Cendan JC, Topping DB, et al: Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res 63: 49-52, 1996.
8. Farias-Eisner R, Sherman MP, Aeberhard E, et al: Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc Natl Acad Sci USA 91: 9407-9411, 1994.
9. Cui S, Reichner JS, Mateo RB, et al: Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res 54: 2462-2467, 1994.
10. Morales A, Eidinger D, and Bruce AW: Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 116: 180-183, 1976.
11. Lamm DL: Optimal BCG treatment of superficial bladder cancer as defined by American trials. Eur Urol 21: 12-16, 1992.
12. Jackson AM, and James K: Understanding the most successful immunotherapy for cancer. Immunologist 2: 208-215, 1994.
13. Ratliff TL, Haaf EO, and Catalona WJ: lnterleukin-2 production during intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. Clin Immunol Immunopathol 40: 375-379, 1986.
14. Fleischmann JD, Toossi Z, Ellner JJ, et al: Urinary interleukins in patients receiving intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. Cancer 64: 1447-1454, 1989.
15. Jackson AM, Alexandroff AB, Kelly RW, et al: Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy. Clin Exp Immunol 99: 369-375, 1995.
16. de Vera ME, Shapiro RA, Nussler AK, et al: Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promotor. Proc Natl Acad Sci USA 93: 1054-1059, 1996.
17. Jansson OT, Morcos E, Brundin L, et al: The role of nitric oxide in BCG-mediated antitumour effects in human bladder cancer. Br J Cancer 78: 588-592, 1998.
18. Rheinwald JG, and Green H: Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 265: 421-424, 1977.
19. 2+-independent nitric oxide synthases. FEBS Lett 291: 145-149, 1991.
20. Papapetropoulos A, Garcia-Cardena G, Madri JA, et al: Nitric oxide production contributes to the angiogenic proper-ties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997.
21. Hibbs JB Jr, Taintor RR, Vavrin Z, et al: Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron, in Moncada S, and Higgs EA (Eds): Nitric Oxide from L-Arginine: A Bioregulatory System. Proceedings of the Symposium on Biological Importance of Nitric Oxide. Amsterdam, Elsevier, 1990, pp 189-223.
22. Schmidt K, Klatt P, and Mayer B: Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells. Biochem J 301: 313-316, 1994.